Precision Neuroscience Corp
StreetZero Signal 76
About Precision Neuroscience Corp
Precision Neuroscience is a neurotechnology company founded in 2021 developing minimally invasive brain-computer interfaces (BCIs) to treat neurological disorders. Its core product, the Layer 7 Cortical Interface, is a thin-film microelectrode array that records high-resolution brain signals from the brain's surface without penetrating or damaging tissue. The company is based in New York, NY and competes in the BCI space against firms such as Neuralink.
LATEST FUNDINGPrivate Placement
$250.0M
Announced 2026-09-28
TOTAL RAISED$248M
IN THE NEWS
- 🔗 Precision Neuroscience - 2026 Company Profile, Team, Funding & Competitors - Tracxn
- 🔗 Precision Neuroscience secures $93m funding
- 🔗 Precision Neuroscience Company Overview, Contact Details & Competitors | LeadIQ
- 🔗 Precision Neuroscience: Funding, Team & Investors | Startup Intros
- 🔗 Precision Neuroscience scores $102M for AI-enabled brain implant
EMPLOYEES—
FOUNDED2021
HQNew York, NY
Industry
Other Health Care
Tags
NeurotechnologyBrain-Computer InterfaceMedical Devices
Investors
Key highlights
- Raised ~$250M including a reported $102M Series C in 2025.
- Layer 7 Cortical Interface avoids brain tissue penetration to reduce damage.
- Competes directly with Neuralink which has raised over $685M.
- Founded by neurosurgeon Ben Rapoport, a Neuralink co-founder.
- Total funding across rounds reported between $161M and $250M.
Ask StreetZero about Precision Neuroscience Corp
Put our AI to work on this deal.
Similar companies
Other Other Health Care deals, ranked by Signal.
Source document & SEC filing
The source SEC filing and the cached document are available to members only. Sign in to view and download them.
Sign in to view the filing Create free account